These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8780735)

  • 1. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system.
    Lundstrom K; Turpin MP
    Biochem Biophys Res Commun; 1996 Aug; 225(3):1068-72. PubMed ID: 8780735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression of G protein-coupled receptors with the aid of the Semliki Forest virus expression system.
    Lundstrom K; Mills A; Allet E; Ceszkowski K; Agudo G; Chollet A; Liljestrom P
    J Recept Signal Transduct Res; 1995; 15(1-4):23-32. PubMed ID: 8903928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system.
    Lundstrom K; Turpin MP; Large C; Robertson G; Thomas P; Lewell XQ
    J Recept Signal Transduct Res; 1998; 18(2-3):133-50. PubMed ID: 9651882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
    Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
    Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ligand-gated ion channels with the Semliki Forest virus expression system.
    Lundstrom K; Michel A; Blasey H; Bernard AR; Hovius R; Vogel H; Surprenant A
    J Recept Signal Transduct Res; 1997; 17(1-3):115-26. PubMed ID: 9029484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    Chio CL; Lajiness ME; Huff RM
    Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
    J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells.
    Hellstrand M; Danielsen EA; Steen VM; Ekman A; Eriksson E; Nilsson CL
    J Med Genet; 2004 Nov; 41(11):867-71. PubMed ID: 15520413
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
    Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG
    Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
    Rybakowski JK; Borkowska A; Czerski PM; Hauser J
    Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association detected between a D3 receptor gene-expressed variant and schizophrenia.
    Rothschild LG; Badner J; Cravchik A; Gershon ES; Gejman PV
    Am J Med Genet; 1996 Apr; 67(2):232-4. PubMed ID: 8723055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene.
    Yang L; Li T; Wiese C; Lannfelt L; Sokoloff P; Xu CT; Zeng Z; Schwartz JC; Liu X; Moises HW
    Am J Med Genet; 1993 Jul; 48(2):83-6. PubMed ID: 8103292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese.
    Soma M; Nakayama K; Rahmutula D; Uwabo J; Sato M; Kunimoto M; Aoi N; Kosuge K; Kanmatsuse K
    Med Sci Monit; 2002 Jan; 8(1):CR1-4. PubMed ID: 11796958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.